Deerfield Management Company, L.P. (Series C) Cytokinetics Inc Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Cytokinetics Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 12,884 shares of CYTK stock, worth $647,034. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,884
Previous 4,366 195.1%
Holding current value
$647,034
Previous $236,000 188.14%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$51.22 - $60.16 $436,291 - $512,442
8,518 Added 195.1%
12,884 $680,000
Q2 2024

Aug 14, 2024
SELL
$47.86 - $75.05 $66,908 - $104,919
-1,398 Reduced 24.25%
4,366 $236,000
Q1 2024

May 15, 2024
BUY
$63.75 - $108.06 $165,750 - $280,956
2,600 Added 82.17%
5,764 $404,000
Q4 2023

Feb 14, 2024
BUY
$26.88 - $83.49 $85,048 - $264,162
3,164 New
3,164 $264,000
Q3 2022

Nov 14, 2022
SELL
$38.54 - $54.52 $13.4 Million - $18.9 Million
-347,203 Reduced 29.92%
813,112 $39.4 Million
Q2 2022

Aug 15, 2022
BUY
$33.93 - $48.92 $7.04 Million - $10.2 Million
207,612 Added 21.79%
1,160,315 $45.6 Million
Q1 2022

May 16, 2022
BUY
$29.74 - $46.0 $4.27 Million - $6.61 Million
143,703 Added 17.76%
952,703 $35.1 Million
Q4 2021

Feb 14, 2022
SELL
$34.35 - $46.38 $25 Million - $33.8 Million
-727,758 Reduced 47.36%
809,000 $36.9 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $5.54 Million - $10.7 Million
298,675 Added 24.12%
1,536,758 $54.9 Million
Q2 2021

Aug 16, 2021
SELL
$19.79 - $26.99 $26.2 Million - $35.7 Million
-1,322,917 Reduced 51.66%
1,238,083 $24.5 Million
Q1 2021

May 17, 2021
BUY
$18.57 - $25.68 $1.86 Million - $2.57 Million
100,000 Added 4.06%
2,561,000 $59.6 Million
Q4 2020

Feb 16, 2021
BUY
$15.26 - $28.61 $37.6 Million - $70.4 Million
2,461,000 New
2,461,000 $51.1 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.73B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email